CFHR1 and complement 3 glomerulopathy: FH autoantibodies are reported in 8-25% of aHUS patients in different cohorts and are strongly associated with homozygous deletion of the CFHR1 gene, but are more rarely reported in patients with C3 glomerulopathies including dense deposit disease (32, 53, 55).